Kang Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kang Xie has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Anming Zhu
Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, Guangdong Pharmaceutical University, Guangzhou, China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, China
1 shared publicationChun Li
1 shared publication- Chun Li
Institute of Formula and Syndrome, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
1 shared publication - Dewei Ye
The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine (Institute of Chinese Medicine), MOE Key Laboratory of Glucolipid Metabolic Disorder, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmaceutical University, Guangzhou, China
1 shared publication - Haowen Zhuang
School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
1 shared publication - Jialing Tang
Central South University
1 shared publication
Latest Publications
- 3 March 2026
- Published by Springer Nature in Cardiovascular Toxicology
- Vol. 26 (3) , 32
Jinxinkang Granule Preserves Myocardial Function by Suppressing Cardiac Senescence Through the cGAS-STING Axis in a Pressure Overload Mouse Model of Heart Failure
Heart failure (HF) is a major cause of morbidity and mortality, and current therapies do not fully prevent adverse remodeling. Traditional Chinese medicine (TCM) formulas are increasingly explored as adjunctive strategies for HF; however, their efficacy and mechanisms require further validation. This study investigated whether Jinxinkang granule (JXK), a clinically used TCM formula, protects against pressure overload–induced HF in mice, and further explored the molecular mechanisms underlying its cardioprotective effects. Pressure overload HF was induced by transverse aortic constriction (TAC) in male C57BL/6J mice. Animals were randomized into control, model, JXK (low, medium, high dose), or positive control (trimetazidine) groups. Cardiac function was assessed by echocardiography, serum biomarkers (NT-proBNP, CK-MB, cTnT) were measured, and cardiac remodeling was assessed by hematoxylin and eosin staining, Masson’s trichrome staining, wheat germ agglutinin staining, and TUNEL assay. Expression of senescence markers (p16, p53, MMP3) and cGAS-STING pathway components was analyzed by qPCR, Western blotting, and immunofluorescence. TAC induced systolic dysfunction, ventricular dilation, cardiomyocyte hypertrophy, fibrosis, and increased apoptosis, accompanied by activation of senescence markers and of cGAS-STING signaling. JXK dose-dependently improved left ventricular ejection fraction and fractional shortening, reduced serum injury biomarkers, attenuated cardiomyocyte hypertrophy and fibrosis, and decreased TUNEL-positive cells. Mechanistically, JXK suppressed TAC-induced upregulation of p16, p53, and MMP3, and inhibited cGAS, STING, p-TBK1, and p-IRF3 activation. JXK preserves cardiac function and attenuates remodeling in pressure overload–induced HF, potentially through inhibition of myocardial senescence and suppression of the cGAS-STING pathway. Graphical Abstract
- 3 March 2026
- Published by Springer Nature in Cardiovascular Toxicology
- Vol. 26 (3) , 32
Jinxinkang Granule Preserves Myocardial Function by Suppressing Cardiac Senescence Through the cGAS-STING Axis in a Pressure Overload Mouse Model of Heart Failure
Heart failure (HF) is a major cause of morbidity and mortality, and current therapies do not fully prevent adverse remodeling. Traditional Chinese medicine (TCM) formulas are increasingly explored as adjunctive strategies for HF; however, their efficacy and mechanisms require further validation. This study investigated whether Jinxinkang granule (JXK), a clinically used TCM formula, protects against pressure overload–induced HF in mice, and further explored the molecular mechanisms underlying its cardioprotective effects. Pressure overload HF was induced by transverse aortic constriction (TAC) in male C57BL/6J mice. Animals were randomized into control, model, JXK (low, medium, high dose), or positive control (trimetazidine) groups. Cardiac function was assessed by echocardiography, serum biomarkers (NT-proBNP, CK-MB, cTnT) were measured, and cardiac remodeling was assessed by hematoxylin and eosin staining, Masson’s trichrome staining, wheat germ agglutinin staining, and TUNEL assay. Expression of senescence markers (p16, p53, MMP3) and cGAS-STING pathway components was analyzed by qPCR, Western blotting, and immunofluorescence. TAC induced systolic dysfunction, ventricular dilation, cardiomyocyte hypertrophy, fibrosis, and increased apoptosis, accompanied by activation of senescence markers and of cGAS-STING signaling. JXK dose-dependently improved left ventricular ejection fraction and fractional shortening, reduced serum injury biomarkers, attenuated cardiomyocyte hypertrophy and fibrosis, and decreased TUNEL-positive cells. Mechanistically, JXK suppressed TAC-induced upregulation of p16, p53, and MMP3, and inhibited cGAS, STING, p-TBK1, and p-IRF3 activation. JXK preserves cardiac function and attenuates remodeling in pressure overload–induced HF, potentially through inhibition of myocardial senescence and suppression of the cGAS-STING pathway. Graphical Abstract
- Open Access
- 25 February 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (3) , 360
Yixinjiedu Formula Attenuates Pressure Overload-Induced Cardiac Dysfunction by Suppressing Ferroptosis and Restoring Mitophagy via the PINK1/Parkin Axis
Background: Pressure overload-induced heart failure (HF) involves cardiac remodeling, ferroptosis, and impaired mitophagy. Yixinjiedu formula (YXJDF), a traditional Chinese medicine, shows cardiovascular protective effects, but its underlying mechanisms remain largely unclear. This study aims to evaluate the cardioprotective effect of YXJDF in pressure overload-induced HF and explore its regulatory role in ferroptosis and mitophagy. Methods: A transverse aortic constriction (TAC) mouse model and angiotensin II-induced HL-1 cardiomyocytes were used to assess the therapeutic effects of YXJDF. Cardiac function, ferroptosis, and mitophagy were evaluated using histological, biochemical, molecular, and imaging analyses. Autophagic flux was assessed using lysosomal inhibition. Network pharmacology was applied to identify potential targets, while LC-MS/MS profiling and molecular docking were used to characterize major constituents of YXJDF and predict target interactions. Results: In TAC mice, YXJDF significantly improved cardiac function and attenuated myocardial hypertrophy and fibrosis. YXJDF suppressed ferroptotic injury, as evidenced by reduced lipid peroxidation, restoration of GPX4 and FTH1 expression, and normalization of antioxidant capacity. Mitophagy was restored, as indicated by increased PINK1 and Parkin expression, enhanced LC3-II accumulation, and reduced p62 and TOM20 levels, and as confirmed by autophagic flux analysis. Consistent protective effects on ferroptosis and mitophagy were observed in angiotensin II-induced cardiomyocytes. Network pharmacology analysis identified PINK1 as a key target, which was validated by in vivo and in vitro experiments. LC-MS/MS identified 20 major chemical constituents in YXJDF, and molecular docking showed strong binding affinity between several compounds (e.g., calycosin, salvianolic acid A) and PINK1. Conclusions: YXJDF ameliorates pressure overload-induced cardiac injury by restoring PINK1/Parkin-mediated mitophagy and suppressing ferroptosis. These findings reveal a multi-target mechanism underlying the therapeutic potential of YXJDF in HF.
- 25 February 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (3) , 360
Open AccessYixinjiedu Formula Attenuates Pressure Overload-Induced Cardiac Dysfunction by Suppressing Ferroptosis and Restoring Mitophagy via the PINK1/Parkin Axis
Background: Pressure overload-induced heart failure (HF) involves cardiac remodeling, ferroptosis, and impaired mitophagy. Yixinjiedu formula (YXJDF), a traditional Chinese medicine, shows cardiovascular protective effects, but its underlying mechanisms remain largely unclear. This study aims to evaluate the cardioprotective effect of YXJDF in pressure overload-induced HF and explore its regulatory role in ferroptosis and mitophagy. Methods: A transverse aortic constriction (TAC) mouse model and angiotensin II-induced HL-1 cardiomyocytes were used to assess the therapeutic effects of YXJDF. Cardiac function, ferroptosis, and mitophagy were evaluated using histological, biochemical, molecular, and imaging analyses. Autophagic flux was assessed using lysosomal inhibition. Network pharmacology was applied to identify potential targets, while LC-MS/MS profiling and molecular docking were used to characterize major constituents of YXJDF and predict target interactions. Results: In TAC mice, YXJDF significantly improved cardiac function and attenuated myocardial hypertrophy and fibrosis. YXJDF suppressed ferroptotic injury, as evidenced by reduced lipid peroxidation, restoration of GPX4 and FTH1 expression, and normalization of antioxidant capacity. Mitophagy was restored, as indicated by increased PINK1 and Parkin expression, enhanced LC3-II accumulation, and reduced p62 and TOM20 levels, and as confirmed by autophagic flux analysis. Consistent protective effects on ferroptosis and mitophagy were observed in angiotensin II-induced cardiomyocytes. Network pharmacology analysis identified PINK1 as a key target, which was validated by in vivo and in vitro experiments. LC-MS/MS identified 20 major chemical constituents in YXJDF, and molecular docking showed strong binding affinity between several compounds (e.g., calycosin, salvianolic acid A) and PINK1. Conclusions: YXJDF ameliorates pressure overload-induced cardiac injury by restoring PINK1/Parkin-mediated mitophagy and suppressing ferroptosis. These findings reveal a multi-target mechanism underlying the therapeutic potential of YXJDF in HF.
- Open Access
- 12 December 2025
- Published by Elsevier in Journal of Traditional Chinese Medical Sciences
- Vol. 13 (1) , 3-11
Thoughts on the scientific research of the connotation of traditional Chinese medicine patterns
- 12 December 2025
- Published by Elsevier in Journal of Traditional Chinese Medical Sciences
- Vol. 13 (1) , 3-11
Open AccessThoughts on the scientific research of the connotation of traditional Chinese medicine patterns